Answers are grounded in this paper and cite their sources.
Normal β-cell physiology should be maintained throughout life. However, it is negatively affected by various factors. Metabolic syndrome is often a predisposing factor for the development of prediabetes and type 2 diabetes mellitus. The main component of MS is visceral obesity, which is accompanied by a number of disorders: insulin resistance, oxidative stress, inflammation, increased levels of free fatty acids. All of these factors lead to impaired β-cell function and/or cell death. β-cell dysfunction and reduction in their mass is one of the causes of type 2 diabetes. Maintaining their secretory function and protecting them from destruction will improve the compensation of patients with type 2 diabetes and slow down its progression. Therefore, antidiabetic therapy should be aimed at preserving β-cells and maintaining their mass. Drugs that affect insulin resistance, drugs with incretin effects, and inhibitors SGLT-2 have a positive effect on pancreatic islet cells.
No takes yet. Share an insight, caveat, or question.
Dolgikh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: